معرفی
Gerald I. Shulman is the George R. Cowgill Professor of Medicine (Endocrinology) and Professor of Cellular and Molecular Physiology at Yale School of Medicine. He serves as Co-Director of the Yale Diabetes Research Center and is an Investigator Emeritus of the Howard Hughes Medical Institute. His primary affiliations include the Department of Internal Medicine, the Department of Cellular & Molecular Physiology, and multiple interdisciplinary centers such as the Yale Diabetes Center, Liver Center, and Yale Cancer Center.
- MD, Wayne State University (1979)
- PhD, Physiology, Wayne State University (1979)
- Residency, Duke University Medical Center (1981)
- Research Fellowship, Massachusetts General Hospital/Harvard Medical School (1984)
Dr. Shulman's research is centered on metabolic regulation, particularly insulin resistance, type 2 diabetes, mitochondrial function, and lipid metabolism. His lab pioneered the use of NMR and mass spectrometry to study intracellular metabolism in vivo, leading to major insights into the role of ectopic fat and mitochondrial flux in metabolic diseases. His work spans rare and common diseases, including NAFLD, NASH, lipodystrophy, and cardiometabolic disorders. He is actively developing novel therapies targeting mitochondrial uncoupling, NAD+ metabolism, and CoA formation.
His recent publications highlight a strong focus on mitochondrial metabolism, insulin signaling, and therapeutic interventions for metabolic diseases. Trends include the development of new methodologies like Q-Flux, the role of hepatic lipolysis in gluconeogenesis, and the cardioprotective mechanisms of SGLT2 inhibitors. His work frequently appears in top journals such as Nature, Science, and Cell Metabolism, reflecting its high impact and translational relevance.
Scientific Awards and Honors:
- Banting Medal for Lifetime Scientific Achievement, American Diabetes Association
- Manpei-Suzuki International Prize for Diabetes Research
- EASD-Lilly Centennial Anniversary Prize
- Stanley J. Korsymeyer Award, American Society for Clinical Investigation
- Solomon Berson Award, American Physiological Society
- Outstanding Clinical Investigator Award, Endocrine Society
- Fellow, American Association for the Advancement of Science
- Inaugural Fellow, American Physiological Society
- Elected Member, National Academy of Sciences
- Elected Member, National Academy of Medicine
- Elected Member, American Academy of Arts and Sciences
Dr. Shulman has led numerous NIH-funded and industry-supported research grants, particularly in diabetes and metabolic disease. He mentors a large research team and has trained many scientists who have gone on to independent careers. He is actively involved in academic leadership, serving as Co-Director of the Yale Diabetes Research Center and as an editor for journals including Journal of Clinical Investigation, Cell Metabolism, and Science Translational Medicine. He also contributes to clinical trials, including studies on adipocyte turnover in obese adolescents.
Dr. Shulman leads the Shulman Lab, which focuses on mitochondrial flux regulation, metabolic disease mechanisms, and novel therapeutic development. The lab is part of the Yale Diabetes Research Center and collaborates extensively with other research groups at Yale, including those of Kitt Petersen, Varman Samuel, and Mario Kahn. The lab employs cutting-edge techniques such as PINTA and Q-Flux to measure in vivo metabolic fluxes in liver, muscle, and brain.